ArticleMRS advances2022
Development of Photoluminescent ZnO Nanoparticles for Biological Tracking.
Article in MRS advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
Nanoparticles (NPs) that can be optically tracked are of interest for cell and organismal biodistribution studies. However, dyes or fluorophores crosslinked or adsorbed onto NP surfaces may detach or leach, resulting in optical artifacts. NP surfaces altered to carry dyes or fluorophores are also anticipated to affect toxicity profiles, protein interactions, and cell uptake. Zinc oxide (ZnO) NPs provide a potential solution. We have produced ZnO nanoparticles with different morphologies and defect emissions in the visible range using sol-gel chemistry. Several of the nanocomposites produced have a wide visible band emission. ZnO semiconductor nanocomposites have broad applications in many fields. They may be dispersed in polymers, functionalized for cell targeting, conjugated to drugs or proteins. We report a unique 600 nm emission peak, which is of interest for nano-bio interaction studies currently limited by autofluorescence in biologicals and the spectral overlap of common fluorescent dyes and proteins.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.